MedPath

Assessment the efficacy of Tranexamic Acid in reducing blood loss after laminectomy and postrolateral fusion of spine

Phase 2
Conditions
Anticoagulant drug.
Anticoagulant antagonists, vitamin K and other coagulants
Registration Number
IRCT2017020913947N6
Lead Sponsor
Vice chancellor for research, Tabriz University of Medical Sciences, Golgasht St, Tabriz, Iran
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Inclusion Criteria:age between 18 to 60 years old ; patients underwent for laminectomy surgery ( 2 level or more) and posterolateral fusion with pedicule screws for reason other than trauma ; Informed consent

Exclusion Criteria

Anticoagulant drugs use such as A.S.A and dipyridamole; Increased in PT, PTT, INR ; History of CVA, MI, bleeding disorder, TBI, CPR, Renal Failure, OCP; Pregnancy and breastfeeding; Patients received pack cell before or during the operation

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood loss. Timepoint: First and 12 hours after surgery and. Method of measurement: First and 12 hours after surgery and the amount of suctioned during surgery.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath